CA: Administration Core

CA:管理核心

基本信息

  • 批准号:
    7507392
  • 负责人:
  • 金额:
    $ 18.33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-09-01 至 2013-04-30
  • 项目状态:
    已结题

项目摘要

THE UNIVERSITY OF TEXAS LUNG CANCER SPORE: ADMINSTRATIVE CORE A RESPONSIBILITIES (University of Texas Southwestern Medical Center and The University of Texas MD Anderson Cancer Center) 1. Responsibility for the overall scientific quality assurance and function of the SPORE, the Scientific Projects and the Core Resources. Communicate and consult with Project Investigators and Core leaders including Developmental and Career Development Project Investigators. Ensure communication, cooperation, and integration between activities at the two different University of Texas sites (UT Southwestern and UT M.D. Anderson Cancer Center). Encourage institutional commitment to the SPORE Program. 2. Responsibility for overall compliance with all general Governmental and specific NCI regulations and requirements. Communicate and consult frequently with the NCI Project Officer and other staff, and be responsible for the preparation of all necessary reports and other reporting requirements. 3. Coordinate data quality control and quality assurance issues in conjunction with the Internal Review and Monitoring Committees of UTSW and MDACC and the Biostatistics and Bioinformatics Cores C and D. 4. Oversee expenditures and maintain budget information. 5. Convene all necessary meetings, including the Executive Committee, External and Internal Advisory Committees, monthly scientific videoconference meetings, lectures, symposia, and attendance at the annual SPORE and the Lung Cancer SPORE meetings. 6. Administer the Developmental Research and Career Development Programs including obtaining mentors, biostatistical, and bioinformatics support and assist the Executive Committee and External Advisors in selection of projects for funding of Developmental and Career Development Projects. Specifically establish and monitor policies for recruitment of women and minorities to this program. 7. Assist with preparation of all publications resulting from the SPORE program. 8. Coordinate, obtain and maintain Institutional commitment to the SPORE at UTSW and MDACC. 9. Encourage and facilitate inter SPORE communication, collaborations, cooperation, data and resource sharing. 10. Coordinate and facilitate SPORE interactions with the PHARMA and Biotech industry 11. Coordinate and facilitate Patient Advocate involvement in the SPORE.
德州大学肺癌孢子:行政核心一项职责

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN D. MINNA其他文献

JOHN D. MINNA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN D. MINNA', 18)}}的其他基金

Developing ASCL1 and NeuroD1 lineage oncogene targeted therapy for small cell lung cancer
开发针对小细胞肺癌的 ASCL1 和 NeuroD1 谱系癌基因靶向治疗
  • 批准号:
    10240702
  • 财政年份:
    2017
  • 资助金额:
    $ 18.33万
  • 项目类别:
Developing ASCL1 and NeuroD1 lineage oncogene targeted therapy for small cell lung cancer
开发针对小细胞肺癌的 ASCL1 和 NeuroD1 谱系癌基因靶向治疗
  • 批准号:
    9767080
  • 财政年份:
    2017
  • 资助金额:
    $ 18.33万
  • 项目类别:
P-1: Molecular Signatures for Individualizing Lung Cancer Therapy
P-1:个体化肺癌治疗的分子特征
  • 批准号:
    8731332
  • 财政年份:
    2013
  • 资助金额:
    $ 18.33万
  • 项目类别:
CA: Administration Core
CA:管理核心
  • 批准号:
    8731339
  • 财政年份:
    2013
  • 资助金额:
    $ 18.33万
  • 项目类别:
P-1: Molecular Signatures for Individualizing Lung Cancer Therapy
P-1:个体化肺癌治疗的分子特征
  • 批准号:
    7507375
  • 财政年份:
    2008
  • 资助金额:
    $ 18.33万
  • 项目类别:
Molecular Pathology of Lung Cancer
肺癌的分子病理学
  • 批准号:
    6943244
  • 财政年份:
    2005
  • 资助金额:
    $ 18.33万
  • 项目类别:
DEVELOPMENTAL RESEARCH PROGRAM
发展研究计划
  • 批准号:
    6395792
  • 财政年份:
    2000
  • 资助金额:
    $ 18.33万
  • 项目类别:
CAREER DEVELOPMENT PROGRAM
职业发展计划
  • 批准号:
    6395793
  • 财政年份:
    2000
  • 资助金额:
    $ 18.33万
  • 项目类别:
IDENTIFICATION OF 3P RECESSIVE ONCOGENES IN LUNG CANCER
肺癌中 3P 隐性癌基因的鉴定
  • 批准号:
    6395787
  • 财政年份:
    2000
  • 资助金额:
    $ 18.33万
  • 项目类别:
CAREER DEVELOPMENT PROGRAM
职业发展计划
  • 批准号:
    6217480
  • 财政年份:
    1999
  • 资助金额:
    $ 18.33万
  • 项目类别:

相似海外基金

Advisory Committees
咨询委员会
  • 批准号:
    7353899
  • 财政年份:
    2006
  • 资助金额:
    $ 18.33万
  • 项目类别:
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
  • 批准号:
    0451289
  • 财政年份:
    2005
  • 资助金额:
    $ 18.33万
  • 项目类别:
    Standard Grant
Advisory Committees
咨询委员会
  • 批准号:
    7557224
  • 财政年份:
  • 资助金额:
    $ 18.33万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7902286
  • 财政年份:
  • 资助金额:
    $ 18.33万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7691385
  • 财政年份:
  • 资助金额:
    $ 18.33万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    8150373
  • 财政年份:
  • 资助金额:
    $ 18.33万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了